These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35292409)

  • 1. Analysis of Angiographic Treatment Response to Intra-Arterial Nimodipine Bolus Injection in Patients with Medically Refractory Cerebral Vasospasm After Spontaneous Subarachnoid Hemorrhage.
    Schacht H; Küchler J; Neumann A; Schramm P; Tronnier VM; Ditz C
    World Neurosurg; 2022 Jun; 162():e457-e467. PubMed ID: 35292409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of nimodipine dose reduction during the high-risk period for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Ditz C; Matone MV; Schwachenwald B; Küchler J
    Neurosurg Rev; 2024 Jan; 47(1):37. PubMed ID: 38191859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transluminal balloon angioplasty for cerebral vasospasm after spontaneous subarachnoid hemorrhage: A single-center experience.
    Schacht H; Küchler J; Boppel T; Leppert J; Ditz C; Schramm P; Neumann A
    Clin Neurol Neurosurg; 2020 Jan; 188():105590. PubMed ID: 31759310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Vasospasm After Spontaneous Subarachnoid Hemorrhage: Angiographic Pattern and Its Impact on the Clinical Course.
    Ditz C; Leppert J; Neumann A; Krajewski KL; Gliemroth J; Tronnier VM; Küchler J
    World Neurosurg; 2020 Jun; 138():e913-e921. PubMed ID: 32247799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk?
    Adami D; Berkefeld J; Platz J; Konczalla J; Pfeilschifter W; Weidauer S; Wagner M
    J Neuroradiol; 2019 Feb; 46(1):15-24. PubMed ID: 29733918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial nimodipine for cerebral vasospasm after subarachnoid haemorrhage: Influence on clinical course and predictors of clinical outcome.
    Bashir A; Andresen M; Bartek J; Cortsen M; Eskesen V; Wagner A
    Neuroradiol J; 2016 Feb; 29(1):72-81. PubMed ID: 26825134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of post-interventional antiplatelet therapy on angiographic vasospasm, delayed cerebral ischemia, and clinical outcome after aneurysmal subarachnoid hemorrhage: a single-center experience.
    Ditz C; Machner B; Schacht H; Neumann A; Schramm P; Tronnier VM; Küchler J
    Neurosurg Rev; 2021 Oct; 44(5):2899-2912. PubMed ID: 33492514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-Arterial Papaverine-Hydrochloride and Transluminal Balloon Angioplasty for Neurointerventional Management of Delayed-Onset Post-Aneurysmal Subarachnoid Hemorrhage Vasospasm.
    Hosmann A; Rauscher S; Wang WT; Dodier P; Bavinzski G; Knosp E; Gruber A
    World Neurosurg; 2018 Nov; 119():e301-e312. PubMed ID: 30053563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Steiger HJ; Ensner R; Andereggen L; Remonda L; Berberat J; Marbacher S
    Acta Neurochir (Wien); 2022 Mar; 164(3):811-821. PubMed ID: 35138488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Nimodipine and Milrinone in Delayed Cerebral Ischemia.
    Kotwal A; Ramalingaiah AH; Shukla D; Radhakrishnan M; Konar SK; Srinivasaiah B; Chakrabarti D; Sundaram M
    World Neurosurg; 2022 Oct; 166():e285-e293. PubMed ID: 35843579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia-continuous selective intracarotid nimodipine therapy in awake patients without sedation.
    Paľa A; Schneider M; Brand C; Pedro MT; Özpeynirci Y; Schmitz B; Wirtz CR; Kapapa T; König R; Braun M
    Neurosurg Rev; 2019 Jun; 42(2):463-469. PubMed ID: 29804157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel rescue therapy for cerebral vasospasm: Cisternal Nimodipine application via stereotactic catheter ventriculocisternostomy.
    Roelz R; Scheiwe C; Coenen VA; Reinacher PC
    J Clin Neurosci; 2019 May; 63():244-248. PubMed ID: 30737093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion.
    Hänggi D; Turowski B; Beseoglu K; Yong M; Steiger HJ
    AJNR Am J Neuroradiol; 2008 Jun; 29(6):1053-60. PubMed ID: 18372422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Cho WS; Kang HS; Kim JE; Kwon OK; Oh CW; Son YJ; Know BJ; Jung C; Hang MH
    Interv Neuroradiol; 2011 Jun; 17(2):169-78. PubMed ID: 21696654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroencephalography for detection of vasospasm and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a retrospective analysis and systematic review.
    Scherschinski L; Catapano JS; Karahalios K; Koester SW; Benner D; Winkler EA; Graffeo CS; Srinivasan VM; Jha RM; Jadhav AP; Ducruet AF; Albuquerque FC; Lawton MT
    Neurosurg Focus; 2022 Mar; 52(3):E3. PubMed ID: 35231893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine use of perfusion computed tomography for the detection of delayed cerebral ischemia in unconscious patients after aneurysmal subarachnoid hemorrhage.
    Ditz C; Hartlieb M; Neumann A; Machner B; Schacht H; Krajewski KL; Leppert J; Tronnier VM; Küchler J
    Acta Neurochir (Wien); 2021 Jan; 163(1):151-160. PubMed ID: 32910294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Alkaline Phosphatase Level is Associated with Angiographic Vasospasm, Delayed Cerebral Ischemia-Caused Clinical Deterioration, and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage.
    Zhu Y; Jiang H; Li Y; Weng Y; Xu K; Zhou L; Lin H; Sun T; Cheng D; Shen J; Zeng J; Ye D; Wang D; Zhan R
    Neurocrit Care; 2019 Dec; 31(3):466-475. PubMed ID: 31016639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early cisternal fibrinolysis is more effective than rescue spasmolysis for the prevention of delayed infarction after subarachnoid haemorrhage.
    Roelz R; Scheiwe C; Grauvogel J; Csok I; Coenen VA; Beck J; Reinacher PC
    Stroke Vasc Neurol; 2022 Apr; 7(2):108-113. PubMed ID: 34750281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.